Genome-wide association study of opioid dependence

Multiple associations mapped to calcium and potassium pathways

Joel Gelernter, Henry R. Kranzler, Richard Sherva, Ryan Koesterer, Laura Almasy, Hongyu Zhao, Lindsay A. Farrer

Research output: Contribution to journalArticle

77 Citations (Scopus)

Abstract

Background We report a genome-wide association study (GWAS) of two populations, African-American and European-American (AA, EA) for opioid dependence (OD) in three sets of subjects, to identify pathways, genes, and alleles important in OD risk. Methods The design employed three phases (on the basis of separate sample collections). Phase 1 included our discovery GWAS dataset consisting of 5697 subjects (58% AA) diagnosed with opioid and/or other substance dependence and control subjects. Subjects were genotyped with the Illumina OmniQuad microarray, yielding 890,000 single nucleotide polymorphisms (SNPs) suitable for analysis. Additional genotypes were imputed with the 1000 Genomes reference panel. Top-ranked findings were further evaluated in Phase 2 by incorporating information from the publicly available Study of Addiction: Genetics and Environment dataset, with GWAS data from 4063 subjects (32% AA). In Phase 3, the most significant SNPs from Phase 2 were genotyped in 2549 independent subjects (32% AA). Analyses were performed with case-control and ordinal trait designs. Results Most significant results emerged from the AA subgroup. Genome-wide-significant associations (p < 5.0 × 10 -8) were observed with SNPs from multiple loci-KCNG2*rs62103177 was most significant after combining results from datasets in every phase of the study. The most compelling results were obtained with genes involved in potassium signaling pathways (e.g., KCNC1 and KCNG2). Pathway analysis also implicated genes involved in calcium signaling and long-term potentiation. Conclusions This is the first study to identify risk variants for OD with GWAS. Our results strongly implicate risk pathways and provide insights into novel therapeutic and prevention strategies and might biologically bridge OD and other non-substance dependence psychiatric traits where similar pathways have been implicated.

Original languageEnglish (US)
Pages (from-to)66-74
Number of pages9
JournalBiological Psychiatry
Volume76
Issue number1
DOIs
StatePublished - Jul 1 2014
Externally publishedYes

Fingerprint

Genome-Wide Association Study
Opioid Analgesics
Potassium
Calcium
Single Nucleotide Polymorphism
Genome
Genes
Calcium Signaling
Long-Term Potentiation
African Americans
Substance-Related Disorders
Psychiatry
Alleles
Genotype
Population
Datasets

Keywords

  • Calcium signaling
  • complex traits
  • convergence
  • genome-wide association
  • opioid dependence
  • potassium

ASJC Scopus subject areas

  • Biological Psychiatry
  • Medicine(all)

Cite this

Gelernter, J., Kranzler, H. R., Sherva, R., Koesterer, R., Almasy, L., Zhao, H., & Farrer, L. A. (2014). Genome-wide association study of opioid dependence: Multiple associations mapped to calcium and potassium pathways. Biological Psychiatry, 76(1), 66-74. https://doi.org/10.1016/j.biopsych.2013.08.034

Genome-wide association study of opioid dependence : Multiple associations mapped to calcium and potassium pathways. / Gelernter, Joel; Kranzler, Henry R.; Sherva, Richard; Koesterer, Ryan; Almasy, Laura; Zhao, Hongyu; Farrer, Lindsay A.

In: Biological Psychiatry, Vol. 76, No. 1, 01.07.2014, p. 66-74.

Research output: Contribution to journalArticle

Gelernter, J, Kranzler, HR, Sherva, R, Koesterer, R, Almasy, L, Zhao, H & Farrer, LA 2014, 'Genome-wide association study of opioid dependence: Multiple associations mapped to calcium and potassium pathways', Biological Psychiatry, vol. 76, no. 1, pp. 66-74. https://doi.org/10.1016/j.biopsych.2013.08.034
Gelernter, Joel ; Kranzler, Henry R. ; Sherva, Richard ; Koesterer, Ryan ; Almasy, Laura ; Zhao, Hongyu ; Farrer, Lindsay A. / Genome-wide association study of opioid dependence : Multiple associations mapped to calcium and potassium pathways. In: Biological Psychiatry. 2014 ; Vol. 76, No. 1. pp. 66-74.
@article{b0e361cc48434f1194bac05e3aebdbab,
title = "Genome-wide association study of opioid dependence: Multiple associations mapped to calcium and potassium pathways",
abstract = "Background We report a genome-wide association study (GWAS) of two populations, African-American and European-American (AA, EA) for opioid dependence (OD) in three sets of subjects, to identify pathways, genes, and alleles important in OD risk. Methods The design employed three phases (on the basis of separate sample collections). Phase 1 included our discovery GWAS dataset consisting of 5697 subjects (58{\%} AA) diagnosed with opioid and/or other substance dependence and control subjects. Subjects were genotyped with the Illumina OmniQuad microarray, yielding 890,000 single nucleotide polymorphisms (SNPs) suitable for analysis. Additional genotypes were imputed with the 1000 Genomes reference panel. Top-ranked findings were further evaluated in Phase 2 by incorporating information from the publicly available Study of Addiction: Genetics and Environment dataset, with GWAS data from 4063 subjects (32{\%} AA). In Phase 3, the most significant SNPs from Phase 2 were genotyped in 2549 independent subjects (32{\%} AA). Analyses were performed with case-control and ordinal trait designs. Results Most significant results emerged from the AA subgroup. Genome-wide-significant associations (p < 5.0 × 10 -8) were observed with SNPs from multiple loci-KCNG2*rs62103177 was most significant after combining results from datasets in every phase of the study. The most compelling results were obtained with genes involved in potassium signaling pathways (e.g., KCNC1 and KCNG2). Pathway analysis also implicated genes involved in calcium signaling and long-term potentiation. Conclusions This is the first study to identify risk variants for OD with GWAS. Our results strongly implicate risk pathways and provide insights into novel therapeutic and prevention strategies and might biologically bridge OD and other non-substance dependence psychiatric traits where similar pathways have been implicated.",
keywords = "Calcium signaling, complex traits, convergence, genome-wide association, opioid dependence, potassium",
author = "Joel Gelernter and Kranzler, {Henry R.} and Richard Sherva and Ryan Koesterer and Laura Almasy and Hongyu Zhao and Farrer, {Lindsay A.}",
year = "2014",
month = "7",
day = "1",
doi = "10.1016/j.biopsych.2013.08.034",
language = "English (US)",
volume = "76",
pages = "66--74",
journal = "Biological Psychiatry",
issn = "0006-3223",
publisher = "Elsevier USA",
number = "1",

}

TY - JOUR

T1 - Genome-wide association study of opioid dependence

T2 - Multiple associations mapped to calcium and potassium pathways

AU - Gelernter, Joel

AU - Kranzler, Henry R.

AU - Sherva, Richard

AU - Koesterer, Ryan

AU - Almasy, Laura

AU - Zhao, Hongyu

AU - Farrer, Lindsay A.

PY - 2014/7/1

Y1 - 2014/7/1

N2 - Background We report a genome-wide association study (GWAS) of two populations, African-American and European-American (AA, EA) for opioid dependence (OD) in three sets of subjects, to identify pathways, genes, and alleles important in OD risk. Methods The design employed three phases (on the basis of separate sample collections). Phase 1 included our discovery GWAS dataset consisting of 5697 subjects (58% AA) diagnosed with opioid and/or other substance dependence and control subjects. Subjects were genotyped with the Illumina OmniQuad microarray, yielding 890,000 single nucleotide polymorphisms (SNPs) suitable for analysis. Additional genotypes were imputed with the 1000 Genomes reference panel. Top-ranked findings were further evaluated in Phase 2 by incorporating information from the publicly available Study of Addiction: Genetics and Environment dataset, with GWAS data from 4063 subjects (32% AA). In Phase 3, the most significant SNPs from Phase 2 were genotyped in 2549 independent subjects (32% AA). Analyses were performed with case-control and ordinal trait designs. Results Most significant results emerged from the AA subgroup. Genome-wide-significant associations (p < 5.0 × 10 -8) were observed with SNPs from multiple loci-KCNG2*rs62103177 was most significant after combining results from datasets in every phase of the study. The most compelling results were obtained with genes involved in potassium signaling pathways (e.g., KCNC1 and KCNG2). Pathway analysis also implicated genes involved in calcium signaling and long-term potentiation. Conclusions This is the first study to identify risk variants for OD with GWAS. Our results strongly implicate risk pathways and provide insights into novel therapeutic and prevention strategies and might biologically bridge OD and other non-substance dependence psychiatric traits where similar pathways have been implicated.

AB - Background We report a genome-wide association study (GWAS) of two populations, African-American and European-American (AA, EA) for opioid dependence (OD) in three sets of subjects, to identify pathways, genes, and alleles important in OD risk. Methods The design employed three phases (on the basis of separate sample collections). Phase 1 included our discovery GWAS dataset consisting of 5697 subjects (58% AA) diagnosed with opioid and/or other substance dependence and control subjects. Subjects were genotyped with the Illumina OmniQuad microarray, yielding 890,000 single nucleotide polymorphisms (SNPs) suitable for analysis. Additional genotypes were imputed with the 1000 Genomes reference panel. Top-ranked findings were further evaluated in Phase 2 by incorporating information from the publicly available Study of Addiction: Genetics and Environment dataset, with GWAS data from 4063 subjects (32% AA). In Phase 3, the most significant SNPs from Phase 2 were genotyped in 2549 independent subjects (32% AA). Analyses were performed with case-control and ordinal trait designs. Results Most significant results emerged from the AA subgroup. Genome-wide-significant associations (p < 5.0 × 10 -8) were observed with SNPs from multiple loci-KCNG2*rs62103177 was most significant after combining results from datasets in every phase of the study. The most compelling results were obtained with genes involved in potassium signaling pathways (e.g., KCNC1 and KCNG2). Pathway analysis also implicated genes involved in calcium signaling and long-term potentiation. Conclusions This is the first study to identify risk variants for OD with GWAS. Our results strongly implicate risk pathways and provide insights into novel therapeutic and prevention strategies and might biologically bridge OD and other non-substance dependence psychiatric traits where similar pathways have been implicated.

KW - Calcium signaling

KW - complex traits

KW - convergence

KW - genome-wide association

KW - opioid dependence

KW - potassium

UR - http://www.scopus.com/inward/record.url?scp=84902198211&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902198211&partnerID=8YFLogxK

U2 - 10.1016/j.biopsych.2013.08.034

DO - 10.1016/j.biopsych.2013.08.034

M3 - Article

VL - 76

SP - 66

EP - 74

JO - Biological Psychiatry

JF - Biological Psychiatry

SN - 0006-3223

IS - 1

ER -